|
Volumn 42, Issue 2, 2004, Pages 357-364
|
Discussion of competitive costs of disclosure by biotech IPOs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
|
EID: 2442538000
PISSN: 00218456
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1475-679X.2004.00141.x Document Type: Note |
Times cited : (15)
|
References (6)
|